Investing.com - Heart Test Laboratories Unt reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Heart Test Laboratories Unt announced earnings per share of $-0.19 on revenue of $3.20K. Analysts polled by Investing.com anticipated EPS of $-0.18 on revenue of $0.00.
Heart Test Laboratories Unt shares are down 0% from the beginning of the year and are trading at $1.36 , down-from-52-week-high.
Heart Test Laboratories Unt follows other major Healthcare sector earnings this month
Heart Test Laboratories Unt's report follows an earnings beat by Medtronic on August 23, who reported EPS of $1.13 on revenue of $7.37B, compared to forecasts EPS of $1.12 on revenue of $7.22B.
Merck ADR had beat expectations on September 9 with third quarter EPS of $0.5392 on revenue of $5.69B, compared to forecast for EPS of $0.5165 on revenue of $5.57B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar